Back to top

ELVN Maintained by Guggenheim -- Price Target Lowered to $78.00

ELVN Maintained by Guggenheim -- Price Target Lowered to $78.00

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Enliven Therapeutics, Inc. (ELVN)